Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Continuation Treatment Study With Levodopa - Carbidopa Intestinal Gel In Subjects With Advanced Parkinson's Disease And Severe Motor-Fluctuations Who Have Exhibited A Persistent And Positive Effect To Treatment In Previous Studies

NCT00660673 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT00660673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00660673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Continuation Treatment Study With Levodopa - Carbidopa Intestinal Gel In Subjects With Advanced Parkinson's Disease And Severe Motor-Fluctuations Who Have Exhibited A Persistent And Positive Effect To Treatment In Previous Studies
Lead sponsor
AbbVie
Phase
Phase 3
Overall status
Completed
Start date
November 13, 2009
Completion date
November 30, 2021
Enrollment
262 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

advanced parkinson's disease